The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Integrins in cancer: biological implications and therapeutic opportunities
Open accessAbstract
The integrin family of cell adhesion receptors regulates a diverse array of cellular functions crucial to the initiation, progression and metastasis of solid tumours. The importance of integrins in several cell types that affect tumour progression has made them an appealing target for cancer therapy. Integrin antagonists, including the αvβ3 and αvβ5 inhibitor cilengitide, have shown encouraging activity in Phase II clinical trials and cilengitide is currently being tested in a Phase III trial in patients with glioblastoma. These exciting clinical developments emphasize the need to identify how integrin antagonists influence the tumour and its microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Self-citationPàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Self-citationMunger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
Integrin-regulated FAK–Src signaling in normal and cancer cells
Mitra, S. K., & Schlaepfer, D. D. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.011 · Cited by 1,590
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Self-citationFrisch, S. M., & Screaton, R. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00251-9 · Cited by 1,249
Pytela, R., Pierschbacher, M. D., & Ruoslahti, E. (1985) · Cell · doi:10.1016/0092-8674(85)90322-8 · Cited by 1,101
Integrins in angiogenesis and lymphangiogenesis
Avraamides, C. J., Garmy-Susini, B., & Varner, J. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2353 · Cited by 1,050
Berrier, A. L., & Yamada, K. M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21237 · Cited by 957
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Self-citationDetection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Self-citationGata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
Asselin-Labat, M.-L., Sutherland, K. D., Barker, H., Thomas, R., Shackleton, M., Forrest, N. C., Hartley, L., Robb, L., Grosveld, F. G., van der Wees, J., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1530 · Cited by 840
N -Methylated Cyclic RGD Peptides as Highly Active and Selective α V β 3 Integrin Antagonists
Dechantsreiter, M. A., Planker, E., Mathä, B., Lohof, E., Hölzemann, G., Jonczyk, A., Goodman, S. L., & Kessler, H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm970832g · Cited by 838
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
Self-citationCellular abnormalities of blood vessels as targets in cancer
Baluk, P., Hashizume, H., & McDonald, D. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.005 · Cited by 781
Albelda, S. M., Mette, S. A., Elder, D. E., Stewart, R., Damjanovich, L., Herlyn, M., & Buck, C. A. (1990) · PubMed · Cited by 760
Miyamoto, S., Teramoto, H., Gutkind, J. S., & Yamada, K. M. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1633 · Cited by 760
Giancotti, F. G., & Ruoslahtl, E. (1990) · Cell · doi:10.1016/0092-8674(90)90098-y · Cited by 746
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Fukumura, D., & Jain, R. K. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.003 · Cited by 691
ILK, PINCH and parvin: the tIPP of integrin signalling
Legate, K. R., Montañez, E., Kudlacek, O., & Füssler, R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1789 · Cited by 676
Tetraspanins: push and pull in suppressing and promoting metastasis
Zöller, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2543 · Cited by 663
A role for VEGF as a negative regulator of pericyte function and vessel maturation
Greenberg, J. I., Shields, D. J., Barillas, S. G., Acevedo, L. M., Murphy, E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R. S., Angle, N., et al. (2008) · Nature · doi:10.1038/nature07424 · Cited by 629
Self-citationRole of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., & Bussolino, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.882 · Cited by 626
Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., & Hodivala-Dilke, K. M. (2002) · Nature Medicine · doi:10.1038/nm0102-27 · Cited by 613
Moro, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6622 · Cited by 584
Integrin activation controls metastasis in human breast cancer
Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1853 · Cited by 577
Cheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 561
Self-citationApoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., & Cheresh, D. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106070 · Cited by 554
Self-citationAumailley, M., Gurrath, M., Müller, G., Calvete, J., Timpl, R., & Kessler, H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81101-d · Cited by 551
Pfaff, M., Tangemann, K., Müller, B., Gurrath, M., Müller, G., Kessler, H., Timpl, R., & Engel, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31981-6 · Cited by 534
Schneller, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5600 · Cited by 492
Haubner, R., Weber, W. A., Beer, A. J., Vabuliene, E., Reim, D., Sarbia, M., Becker, K.-F., Goebel, M., Hein, R., Wester, H.-J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020070 · Cited by 489
Cell adhesion protein receptors as targets for transforming growth factor-$beta; action
IGNOTZ, R. (1987) · Cell · doi:10.1016/0092-8674(87)90146-2 · Cited by 485
NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival
Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F., & Giachelli, C. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1083 · Cited by 485
Reardon, D. A., Fink, K. L., Mikkelsen, T., Cloughesy, T. F., O'Neill, A., Plotkin, S., Glantz, M., Ravin, P., Raizer, J. J., Rich, K. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7510 · Cited by 481
β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis
Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W. J., Inghirami, G., & Giancotti, F. G. (2006) · Cell · doi:10.1016/j.cell.2006.05.047 · Cited by 455
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Self-citationStupp, R., Hegi, M. E., Neyns, B., Goldbrunner, R., Schlegel, U., Clement, P. M. J., Grabenbauer, G. G., Ochsenbein, A. F., Simon, M., Dietrich, P.-Y., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6650 · Cited by 454
Reconstructing and Deconstructing Agonist-Induced Activation of Integrin αIIbβ3
Han, J., Lim, C. J., Watanabe, N., Soriani, A., Ratnikov, B., Calderwood, D. A., Puzon-McLaughlin, W., Lafuente, E. M., Boussiotis, V. A., Shattil, S. J., et al. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.035 · Cited by 448
A Mechanism for Modulation of Cellular Responses to VEGF Activation of the Integrins
Byzova, T. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00083-6 · Cited by 438
A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00567-0 · Cited by 420
Gladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Self-citationWhite, D. E., Kurpios, N. A., Zuo, D., Hassell, J. A., Blaess, S., Mueller, U., & Muller, W. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.025 · Cited by 413
Caswell, P. T., Chan, M., Lindsay, A. J., McCaffrey, M. W., Boettiger, D., & Norman, J. C. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200804140 · Cited by 388
Bates, R. C., Bellovin, D. I., Brown, C., Maynard, E., Wu, B., Kawakatsu, H., Sheppard, D., Oettgen, P., & Mercurio, A. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523183 · Cited by 380
Moro, L., Dolce, L., Cabodi, S., Bergatto, E., Erba, E. B., Smeriglio, M., Turco, E., Retta, S. F., Giuffrida, M. G., Venturino, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109101200 · Cited by 377
Winter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 371
Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 369
Self-citationWayner, E. A., Orlando, R. A., & Cheresh, D. A. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.4.919 · Cited by 358
Self-citationαvβ3 and αvβ5 Integrin Expression in Glioma Periphery
Bello, L., Francolini, M., Marthyn, P., Zhang, J., Carroll, R. S., Nikas, D. C., Strasser, J. F., Villani, R., Cheresh, D. A., & Black, P. M. (2001) · Neurosurgery · doi:10.1097/00006123-200108000-00022 · Cited by 341
Self-citationDavis, G. E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91834-d · Cited by 337
Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli
Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G., & Cheresh, D. A. (2003) · Science · doi:10.1126/science.1082015 · Cited by 336
Self-citationZhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to α v -Integrins
Leong-Poi, H., Christiansen, J., Klibanov, A. L., Kaul, S., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000044916.05919.8b · Cited by 334
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen, M. L., Oyen, W. J. G., Dijkgraaf, I., Massuger, L. F. A. G., Frielink, C., Edwards, D. S., Rajopadhye, M., Boonstra, H., Corstens, F. H. M., & Boerman, O. C. (2002) · PubMed · Cited by 331
Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.
Aznavoorian, S., Stracke, M. L., Krutzsch, H., Schiffmann, E., & Liotta, L. A. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1427 · Cited by 328
Park, C. C., Zhang, H., Pallavicini, M., Gray, J. W., Baehner, F., Park, C. J., & Bissell, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3071 · Cited by 326
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells
Aoudjit, F., & Vuori, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204554 · Cited by 325
Conformation/activity studies of rationally designed potent anti‐adhesive RGD peptides
GURRATH, M., MÜLLER, G., KESSLER, H., AUMAILLEY, M., & TIMPL, R. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17495.x · Cited by 317
Vaillant, F., Asselin-Labat, M.-L., Shackleton, M., Forrest, N. C., Lindeman, G. J., & Visvader, J. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1949 · Cited by 314
Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis
Mahabeleshwar, G. H., Feng, W., Reddy, K., Plow, E. F., & Byzova, T. V. (2007) · Circulation Research · doi:10.1161/circresaha.107.155655 · Cited by 298
An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
Desgrosellier, J. S., Barnes, L. A., Shields, D. J., Huang, M., Lau, S. K., Prévost, N., Tarin, D., Shattil, S. J., & Cheresh, D. A. (2009) · Nature Medicine · doi:10.1038/nm.2009 · Cited by 293
Self-citationBorges, E., Jan, Y., & Ruoslahti, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007040200 · Cited by 293
Matrix Attachment Regulates FAS-Induced Apoptosis in Endothelial Cells
Aoudjit, F., & Vuori, K. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.3.633 · Cited by 291
Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma
Nabors, L. B., Mikkelsen, T., Rosenfeld, S. S., Hochberg, F., Akella, N. S., Fisher, J. D., Cloud, G. A., Zhang, Y., Carson, K., Wittemer, S. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6514 · Cited by 290
Hartmann, T. N., Burger, J. A., Glodek, A., Fujii, N., & Burger, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208621 · Cited by 280
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
Petitclerc, É., Strömblad, S., Schalscha, T. V., Mitjans, F., Piulats, J., Montgomery, A. M. P., Cheresh, D. A., & Brooks, P. C. (1999) · PubMed · Cited by 279
Self-citationPotentiation of neuroblastoma metastasis by loss of caspase-8
Stupack, D. G., Teitz, T., Potter, M. D., Mikolon, D., Houghton, P. J., Kidd, V. J., Lahti, J. M., & Cheresh, D. A. (2006) · Nature · doi:10.1038/nature04323 · Cited by 277
Self-citationTumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone
Sloan, E. K., Pouliot, N., Stanley, K. L., Chia, J., Moseley, J. M., Hards, D. K., & Anderson, R. L. (2006) · Breast Cancer Research · doi:10.1186/bcr1398 · Cited by 275
Klemke, R. L., Yebra, M., Bayna, E. M., & Cheresh, D. A. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.3.859 · Cited by 270
Self-citationDifferential αv integrin–mediated Ras-ERK signaling during two pathways of angiogenesis
Hood, J. D., Frausto, R., Kiosses, W. B., Schwartz, M. A., & Cheresh, D. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304105 · Cited by 262
Self-citationPylayeva, Y., Gillen, K. M., Gerald, W., Beggs, H. E., Reichardt, L. F., & Giancotti, F. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37160 · Cited by 261
Growth control by intracellular tension and extracellular stiffness
Assoian, R. K., & Klein, E. A. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.05.002 · Cited by 258
Galliher, A. J., & Schiemann, W. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3851 · Cited by 249
Varner, J. A., Emerson, D. A., & Juliano, R. L. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.6.725 · Cited by 245
A Signaling Pathway from the α5β1 and αvβ3 Integrins That Elevatesbcl-2 Transcription
Matter, M. L., & Ruoslahti, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102014200 · Cited by 244
MacDonald, T. J., Taga, T., Shimada, H., Tabrizi, P., Zlokovic, B. V., Cheresh, D. A., & Laug, W. E. (2001) · Neurosurgery · doi:10.1097/00006123-200101000-00026 · Cited by 240
Self-citationWhite, D. P., Caswell, P. T., & Norman, J. C. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200609004 · Cited by 239
Trikha, M., Zhao, Z., Tímár, J., Raso, E., Kennel, M., Emmell, E., & Nakada, M. T. (2002) · PubMed · Cited by 237
Galliher, A. J., & Schiemann, W. P. (2006) · Breast Cancer Research · doi:10.1186/bcr1524 · Cited by 236
Platelet and osteoclast β 3 integrins are critical for bone metastasis
Bakewell, S. J., Nestor, P., Prasad, S., Tomasson, M. H., Dowland, N., Mehrotra, M., Scarborough, R., Kanter, J., Abe, K., Phillips, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234372100 · Cited by 233
Zutter, M. M., Santoro, S. A., Staatz, W. D., & Tsung, Y. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7411 · Cited by 232
A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature
Jin, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24751 · Cited by 225
Stoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parry, G. C., Parikh, A. A., McCarty, M. F., Bucana, C. D., Mazar, A. P., & Ellis, L. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10958 · Cited by 224
Integrin β4 signaling promotes tumor angiogenesis
Nikolopoulos, S. N., Blaikie, P., Yoshioka, T., Guo, W., & Giancotti, F. G. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.029 · Cited by 220
Garmy-Susini, B., Jin, H., Zhu, Y., Sung, R.-J., Hwang, R., & Varner, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23445 · Cited by 216
MicroPET imaging of breast cancer ?-integrin expression with Cu-labeled dimeric RGD peptides
CHEN, X., LIU, S., HOU, Y., TOHME, M., PARK, R., BADING, J., & CONTI, P. (2004) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2004.06.004 · Cited by 212
Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases
Zhao, Y., Bachelier, R., Treilleux, I., Pujuguet, P., Peyruchaud, O., Baron, R., Clément-Lacroix, P., & Clézardin, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4499 · Cited by 210
Hsu, M.-Y., Shih, D.-T., Meier, F. E., Van Belle, P., Hsu, J.-Y., Elder, D. E., Buck, C. A., & Herlyn, M. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65730-6 · Cited by 208
Luo, M., Fan, H., Nagy, T., Wei, H., Wang, C., Liu, S., Wicha, M. S., & Guan, J.-L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3078 · Cited by 208
Han, S., Khuri, F. R., & Roman, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2367 · Cited by 207
Prostate cancer specific integrin αvβ3 modulates bone metastatic growth and tissue remodeling
McCabe, N. P., De, S., Vasanji, A., Brainard, J., & Byzova, T. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210429 · Cited by 207
Khalili, P., Arakelian, A., Chen, G., Plunkett, M. L., Beck, I., Parry, G. C., Doñate, F., Shaw, D. E., Mazar, A. P., & Rabbani, S. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0100 · Cited by 203
Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression
Lahlou, H., Sanguin-Gendreau, V., Zuo, D., Cardiff, R. D., McLean, G. W., Frame, M. C., & Muller, W. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710091104 · Cited by 196
Friedrichs, K., Ruiz, P., Franke, F. A., Gille, I., Terpe, H.-J., & Imhof, B. A. (1995) · PubMed · Cited by 195
Cai, W., Wu, Y., Chen, K., Cao, Q., Tice, D. A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1480 · Cited by 187
Integrin αvβ3 Expression by Bone-residing Breast Cancer Metastases
Liapis, H., Flath, A., & Kitazawa, S. (1996) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199606000-00008 · Cited by 186
Cianfrocca, M. E., Kimmel, K. A., Gallo, J., Cardoso, T., Brown, M. M., Hudes, G., Lewis, N., Weiner, L., Lam, G. N., Brown, S. C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603171 · Cited by 184
CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins
Engl, T., Relja, B., Marian, D., Blumenberg, C., Müller, I., Beecken, W.-D., Jones, J., Ringel, E. M., Bereiter-Hahn, J., Jonas, D., et al. (2006) · Neoplasia · doi:10.1593/neo.05694 · Cited by 179
Hazelbag, S., Kenter, G., Gorter, A., Dreef, E., Koopman, L., Violette, S., Weinreb, P., & Fleuren, G. (2007) · The Journal of Pathology · doi:10.1002/path.2168 · Cited by 178
VEGF–integrin interplay controls tumor growth and vascularization
De, S., Razorenova, O., McCabe, N. P., O'Toole, T., Qin, J., & Byzova, T. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502935102 · Cited by 178
Reynolds, A. R., Reynolds, L. E., Nagel, T., Lively, J. C., Robinson, S. D., Hicklin, D. J., Bodary, S. C., & Hodivala‐Dilke, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2760 · Cited by 175
Nip, J., Shibata, H., Loskutoff, D. J., Cheresh, D. A., & Brodt, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116007 · Cited by 172
Self-citationSun, Y., Fang, M., Wang, J., Cooper, C. R., Pienta, K. J., & Taichman, R. S. (2007) · The Prostate · doi:10.1002/pros.20500 · Cited by 171
Brooks, P. C., Klemke, R. L., Schon, S., Lewis, J. M., Schwartz, M. A., & Cheresh, D. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119298 · Cited by 168
Self-citationZhu, C.-Q., Popova, S. N., Brown, E. R. S., Barsyte-Lovejoy, D., Navab, R., Shih, W., Li, M., Lu, M., Jurisica, I., Penn, L. Z., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703040104 · Cited by 167
Uhm, J. H., Dooley, N. P., Kyritsis, A. P., Rao, J., & Gladson, C. L. (1999) · PubMed · Cited by 165
Role of β3 Integrins in Melanoma Cell Adhesion to Activated Platelets under Flow
Felding-Habermann, B., Habermann, R., Saldívar, E., & Ruggeri, Z. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5892 · Cited by 164
Trikha, M., Zhao, Z., Nemeth, J. A., Chen, Q., Sharp, C. M., Emmell, E., Giles-Komar, J. M., & Nakada, M. T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20116 · Cited by 163
Ricart, A. D., Tolcher, A. W., Liu, G., Holen, K., Schwartz, G., Albertini, M., Weiss, G., Yazji, S., Ng, C., & Wilding, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0378 · Cited by 162
Reinmuth, N., Liu, W., Ahmad, S. A., Fan, F., Stoeltzing, O., Parikh, A. A., Bucana, C. D., Gallick, G. E., Nickols, M. A., Westlin, W., et al. (2003) · PubMed · Cited by 160
MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide
Chen, X. S., Park, R. J.-H., Hou, Y., Khankaldyyan, V., Gonzales-Gomez, I., Tohme, M. S., Bading, J. R., Laug, W. E., & Conti, P. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1452-2 · Cited by 158
McNeel, D. G., Eickhoff, J. C., Lee, F. T., King, D. M., Alberti, D. B., Thomas, J. P., Friedl, A., Kolesar, J., Marnocha, R., Volkman, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0262 · Cited by 156
Koopman Van Aarsen, L. A., Leone, D. R., Ho, S., Dolinski, B. M., McCoon, P. E., LePage, D. J., Kelly, R., Heaney, G., Rayhorn, P., Reid, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2307 · Cited by 146
Mullamitha, S., Ton, N. C., Parker, G. J. M., Jackson, A., Julyan, P. J., Roberts, C., Buonaccorsi, G. A., Watson, Y., Davies, K. E., Cheung, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2779 · Cited by 146
Ricono, J. M., Huang, M., Barnes, L. A., Lau, S. K. M., Weis, S. M., Schlaepfer, D. D., Hanks, S. K., & Cheresh, D. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3612 · Cited by 145
Self-citationMacDonald, T. J., Stewart, C. F., Koçak, M., Goldman, S., Ellenbogen, R. G., Phillips∥, P. C., Lafond, D. A., Poussaint, T. Y., Kieran, M. W., Boyett, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1812 · Cited by 144
Hosotani, R., Kawaguchi, M., Masui, T., Koshiba, T., Ida, J., Fujimoto, K., Wada, M., Doi, R., & Imamura, M. (2002) · Pancreas · doi:10.1097/00006676-200208000-00021 · Cited by 143
Fransvea, E., Mazzocca, A., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22731 · Cited by 140
Adachi, M., Taki, T., Higashiyama, M., Kohno, N., Inufusa, H., & Miyake, M. (2000) · PubMed · Cited by 139
Smith, J. W., Ruggeri, Z. M., Kunicki, T. J., & Cheresh, D. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38340-1 · Cited by 136
Self-citationWang, S. E., Xiang, B., Zent, R., Quaranta, V., Pozzi, A., & Arteaga, C. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2649 · Cited by 136
EFFECT OF THE ANGIOGENESIS INHIBITOR CILENGITIDE (EMD 121974) ON GLIOBLASTOMA GROWTH IN NUDE MICE
Yamada, S., Bu, X., Khankaldyyan, V., Gonzales-Gomez, I., McComb, J. G., & Laug, W. E. (2006) · Neurosurgery · doi:10.1227/01.neu.0000245622.70344.be · Cited by 135
Role of the F-Box Protein Skp2 in Adhesion-Dependent Cell Cycle Progression
Carrano, A. C., & Pagano, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.7.1381 · Cited by 134
Cardones, A. R., Murakami, T., & Hwang, S. T. (2003) · PubMed · Cited by 134
Takayama, S., Ishii, S., Ikeda, T., Masamura, S., Doi, M., & Kitajima, M. (2005) · PubMed · Cited by 134
Bertotti, A., Comoglio, P. M., & Trusolino, L. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605114 · Cited by 132
Yang, C., Zeisberg, M., Lively, J. C., Nyberg, P., Afdhal, N. H., & Kalluri, R. (2003) · PubMed · Cited by 130
Integrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors
Jin, H., Su, J., Garmy-Susini, B., Kleeman, J., & Varner, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2704 · Cited by 127
Ludbrook, S. B., Barry, S. T., Delves, C. J., & Horgan, C. M. T. (2003) · Biochemical Journal · doi:10.1042/bj20020809 · Cited by 126
Danen, E. H. J., ten Berge, P. J. M., van Muijen, G. N. P., Hof‐Grootenboer, A. E. V., Bröcker, E. ‐., & Ruiter, D. J. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb00517.x · Cited by 123
Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer
Landen, C. N., Kim, T.-J., Lin, Y. G., Merritt, W. M., Kamat, A. A., Han, L. Y., Spannuth, W. A., Nick, A. M., Jennnings, N. B., Kinch, M. S., et al. (2008) · Neoplasia · doi:10.1593/neo.08740 · Cited by 120
Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.
Bach‐Gansmo, T., Danielsson, R., Saracco, A., et al. (2006) · PubMed · Cited by 119
Increased tumor cell dissemination and cellular senescence in the absence of β1‐integrin function
Kren, A., Baeriswyl, V., Lehembre, F., Wunderlin, C., Strittmatter, K., Antoniadis, H., Fässler, R., Cavallaro, U., & Christofori, G. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601738 · Cited by 113
Superactivation of integrin αvβ3 by low antagonist concentrations
Legler, D. F., Wiedle, G., Ross, F. P., & Imhof, B. A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.8.1545 · Cited by 112
A small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis
Harms, J. F., Welch, D. R., Samant, R. S., Shevde, L. A., Miele, M. E., Babu, G. R., Goldberg, S. F., Gilman, V. R., Sosnowski, D. M., Campo, D. A., et al. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024763.69809.64 · Cited by 109
Winter, P. M., Schmieder, A. H., Caruthers, S. D., Keene, J. L., Zhang, H., Wickline, S. A., & Lanza, G. M. (2008) · The FASEB Journal · doi:10.1096/fj.07-103929 · Cited by 105
Delbaldo, C., Raymond, É., Vera, K., Hammershaimb, L., Kaucic, K., Lozahic, S., Marty, M. E., & Faivre, S. J. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9077-0 · Cited by 101
Wu, L., Bernard‐Trifilo, J. A., Lim, Y., Lim, S.-T., Mitra, S. K., Uryu, S. A., Chen, M., Pallen, C. J., Cheung, N. K., Mikolon, D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210770 · Cited by 101
Increased primary tumor growth in mice null for β3- or β3/β5-integrins or selectins
Taverna, D., Moher, H., Crowley, D. G., Borsig, L., Varki, A. P., & Hynes, R. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307289101 · Cited by 101
αVβ3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer
Vellon, L., Menendez, J. A., & Lupu, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208452 · Cited by 98
Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody, Abegrin™
Mulgrew, K. A., Kinneer, K., Yao, X.-T., Ward, B. K., Damschroder, M. M., Walsh, B., Mao, S.-Y., Gao, C., Kiener, P. A., Coats, S., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0356 · Cited by 96
Chen, Q., Manning, C. D., Millar, H. J., McCabe, F. L., Ferrante, C. A., Sharp, C. M., Shahied-Arruda, L., Doshi, P. D., Nakada, M. T., & Anderson, G. M. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9132-4 · Cited by 92
Bhaskar, V., Zhang, D., Fox, M., Seto, P., Wong, M. H. L., Wales, P., Powers, D., Chao, D. T., DuBridge, R. B., & Ramakrishnan, V. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-61 · Cited by 87
Unoccupied αvβ3Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal
Zhao, H., Ross, F. P., & Teitelbaum, S. L. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0161 · Cited by 85
Diaz, L. K., Cristofanilli, M., Zhou, X., Welch, K., Smith, T. L., Yang, Y., Sneige, N., Şahin, A. A., & Gilcrease, M. Z. (2005) · Modern Pathology · doi:10.1038/modpathol.3800411 · Cited by 82
αvβ6 Integrin Promotes the Invasion of Morphoeic Basal Cell Carcinoma through Stromal Modulation
Marsh, D. J., Dickinson, S., Neill, G. W., Marshall, J. F., Hart, I. R., & Thomas, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0174 · Cited by 81
Beekman, K. W., Colevas, A. D., Cooney, K. A., DiPaola, R. S., Dunn, R. L., Gross, M. E., Keller, E. T., Pienta, K. J., Ryan, C. J., Smith, D. C., et al. (2006) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2006.n.012 · Cited by 80
Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme
Veeravagu, A., Liu, Z., Niu, G., Chen, K., Jia, B., Cai, W., Jin, C., Hsu, A. R., Connolly, A. J., Tse, V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0797 · Cited by 80
Cooperation between VEGF and β3 integrin during cardiac vascular development
Weis, S. M., Lindquist, J. N., Barnes, L. A., Lutu-Fuga, K. M., Cui, J., Wood, M. R., & Cheresh, D. A. (2006) · Blood · doi:10.1182/blood-2005-10-038893 · Cited by 77
Self-citationAnti-metastatic properties of RGD-peptidomimetic agents S137 and S247
Shannon, K. E., Keene, J. L., Settle, S. L., Duffin, T. D., Nickols, M. A., Westlin, M. M., Schroeter, S., Ruminski, P., & Griggs, D. W. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024764.93092.5f · Cited by 76
Rac-dependent cyclin D1 gene expression regulated by cadherin- and integrin-mediated adhesion
Fournier, A. K., Campbell, L. E., Castagnino, P. A., Liu, W. F., Chung, B. M., Weaver, V. M., Chen, C. S., & Assoian, R. K. (2008) · Journal of Cell Science · doi:10.1242/jcs.017012 · Cited by 73
Conti, J. A., Kendall, T. J., Bateman, A. C., Armstrong, T., Papa-Adams, A., Xu, Q., Packham, G., Primrose, J. M., Benyon, R. C., & Iredale, J. P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0816 · Cited by 72
Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature
Cao, L., Du, P., Jiang, S.-H., Jin, G., Huang, Q.-L., & Hua, Z. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0533 · Cited by 71
Spangenberg, C., Lausch, E. U., Trost, T. M., Prawitt, D., May, A., Keppler, R., Fees, S. A., Reutzel, D., Bell, C., Schmitt, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2823 · Cited by 70
α v β 3 Integrin‐targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide
Dijkgraaf, I., Kruijtzer, J. A. W., Frielink, C., Corstens, F. H. M., Oyen, W. J. G., Liskamp, R. M. J., & Boerman, O. C. (2006) · International Journal of Cancer · doi:10.1002/ijc.22297 · Cited by 69
Pouliot, N., Nice, E. C., & Burgess, A. W. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5197 · Cited by 67
Gruber, G., Hess, J., Stiefel, C., Aebersold, D. M., Zimmer, Y., Greiner, R. H., Studer, U. E., Altermatt, H. J., Hlushchuk, R., & Djonov, V. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602278 · Cited by 66
Src Kinase Activity Is Required for Integrin αVβ3-Mediated Activation of Nuclear Factor-κB
Courter, D. L., Lomas, L., Scatena, M., & Giachelli, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412555200 · Cited by 64
Samanna, V., Wei, H., Ego-Osuala, D., & Chellaiah, M. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.022 · Cited by 63
Bao, W., & Strömblad, S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404018 · Cited by 59
Integrin β3 Overexpression Suppresses Tumor Growth in a Human Model of Gliomagenesis
Kanamori, M., VandenBerg, S., Bergers, G., Berger, M. S., & Pieper, R. O. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3354 · Cited by 58
The Met Receptor and α6β4 Integrin Can Function Independently to Promote Carcinoma Invasion
Chung, J., Yoon, S.-O., Lipscomb, E. A., & Mercurio, A. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403809200 · Cited by 56
Integrin αvβ3 Controls Activity and Oncogenic Potential of Primed c-Src
Huveneers, S., van den Bout, I., Sonneveld, P., Sancho, A., Sonnenberg, A., & Danen, E. H. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3654 · Cited by 55
Hersey, P., Sosman, J. A., O'Day, S. J., Richards, J. M., Bedikian, A. Y., González, R., Sharfman, W., Weber, R., Logan, T. F., & Kirkwood, J. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.7507 · Cited by 55
Gramoun, A., Shorey, S., Bashutski, J. D., Dixon, S. J., Sims, S. M., Heersche, J. N. M., & Manolson, M. F. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21296 · Cited by 54
Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody.
Kuwada, S. K. (2007) · PubMed · Cited by 49
Ning, Y., Zeineldin, R., Liu, Y., Rosenberg, M. J., Stack, M. S., & Hudson, L. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0407 · Cited by 49
The angiogenic response is dictated by β3 integrin on bone marrow–derived cells
Feng, W., McCabe, N. P., Mahabeleshwar, G. H., Somanath, P. R., Phillips, D. R., & Byzova, T. V. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200802179 · Cited by 48
Odekon, L. E., Frewin, M. B., Vecchio, P. D., Saba, T. M., & Gudewicz, P. W. (1991) · PubMed Central · Cited by 48
Control of Type II Transforming Growth Factor-β Receptor Expression by Integrin Ligation
Wang, D., Sun, L., Zborowska, E., Willson, J. K. V., Gong, J., Verraraghavan, J., & Brattain, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12840 · Cited by 46
Loss of Integrin α1β1 Ameliorates Kras-Induced Lung Cancer
Macias‐Perez, I., Borza, C. M., Chen, X., Yan, X. S., Ibanez, R., Mernaugh, G., Matrisian, L. M., Zent, R., & Pozzi, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1395 · Cited by 46
Taverna, D., Crowley, D. G., Connolly, M. K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4098 · Cited by 45
Martin, P. L., Jiao, Q., Cornacoff, J. B., Hall, W. C., Saville, B. A., Nemeth, J. A., Schantz, A., Mata, M., Jang, H., Fasanmade, A. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2623 · Cited by 42
Ong, H. T., Trejo, T. R., Pham, L., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.39 · Cited by 36
αv Integrin-Targeted Immunoconjugates Regress Established Human Tumors in Xenograft Models
Chen, Q., Millar, H. J., McCabe, F. L., Manning, C. D., Steeves, R. M., Lai, K., Kellogg, B. A., Lutz, R. J., Trikha, M., Nakada, M. T., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0026 · Cited by 35
Integrins Uncouple Src-induced Morphological and Oncogenic Transformation
Huveneers, S., Arslan, S., van de Water, B., Sonnenberg, A., & Danen, E. H. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800927200 · Cited by 34
Danen, E. H. J., van Kraats, A. A., Cornelissen, I. M. H. A., Ruiter, D. J., & van Muijen, G. N. P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1313 · Cited by 34
Wei, Y., Chen, Y., Hsiao, Y., Huang, Y., Lai, T.-H., & Tang, C. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20411 · Cited by 30
Ribatti, D. (2007) · Endothelium · doi:10.1080/10623320701421651 · Cited by 12
Cited by
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825
Metadata
- Authors
- Desgrosellier, J. S., & Cheresh, D. A.
- Venue
- Nature Reviews Cancer
- Published
- 2010-01
- Volume
- 10
- Issue
- 1
- Pages
- 9-22
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2147000598
- Cited by
- 3,736
- References
- 183
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.